B. King

发表

Disruption to control network function correlates with altered dynamic connectivity in the wider autism spectrum

V. Calhoun, N. de Lacy, D. Doherty, 2017, NeuroImage: Clinical.

Practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorder.

F. Volkmar, B. King, J. McCracken, 2014, Journal of the American Academy of Child and Adolescent Psychiatry.

Consensus Paper: Pathological Role of the Cerebellum in Autism

Matthew W. Mosconi, Stephen R. Dager, A. Estes, 2012, The Cerebellum.

Overemphasis of the ADOS Evaluation Subverts a Clinician's Ability to Provide Access to Autism Services.

Kathleen A. Koth, B. King, M. Fadus, 2019, Journal of the American Academy of Child and Adolescent Psychiatry.

Adolescents With Eating Disorders in Pediatric Practice – The European Academy of Paediatrics Recommendations

A. Valiulis, B. King, A. Mazur, 2022, Frontiers in Pediatrics.

Molecular screening for proximal 15q abnormalities in a mentally retarded population.

D. Ledbetter, S. Christian, B. Leventhal, 1998, Journal of medical genetics.

Association Between Maternal Use of SSRI Medications and Autism in Their Children.

B. King, 2017, JAMA.

Intellectual Disability: Understanding Its Development, Causes,Classification, Evaluation, and Treatment

B. King, Bryan H. King, 2008 .

Psychiatric comorbidities in neurodevelopmental disorders.

B. King, 2016, Current opinion in neurology.

The Quality of Health Care for Adults with Developmental Disabilities

B. King, B. Leake, M. Lewis, 2002, Public health reports.

Practice Parameter for the Assessment and Treatment of Psychiatric Disorders in Children and Adolescents With Intellectual Disability (Intellectual Developmental Disorder).

B. King, J. Veenstra-VanderWeele, M. Siegel, 2020, Journal of the American Academy of Child and Adolescent Psychiatry.

Intellectual Disability (Mental Retardation)

B. King, A. Maerlender, L. Carlisle, 2012 .

Psychiatric assessment of severe presentations in autism spectrum disorders and intellectual disability.

N. de Lacy, B. King, M. Siegel, 2014, Child and adolescent psychiatric clinics of North America.

Genetic and epigenetic signatures associated with plasma oxytocin levels in children and adolescents with autism spectrum disorder

Lauren C. Shuffrey, A. Kolevzon, C. McDougle, 2022, medRxiv.

Maladaptive behaviour in children and adolescents with Down's syndrome.

B. King, E. Dykens, Jaclyn Sagun, 2002, Journal of intellectual disability research : JIDR.

Case series: amantadine open-label treatment of impulsive and aggressive behavior in hospitalized children with developmental disabilities.

B. King, C. Dourish, M. Snape, 2001, Journal of the American Academy of Child and Adolescent Psychiatry.

Pemoline produces ipsilateral turning behavior in unilateral 6-OHDA-lesioned rats

H. C. Cromwell, B. King, E. A. Witte, 1996, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Simple versus Complex Conduct Disorders: Identification and Phenomenology

B. King, C. Kasari, K. Kavale, 1994 .

Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trial.

J. Bregman, E. Hollander, E. Anagnostou, 2013, JAMA pediatrics.

DSM-5 and autism: kicking the tires and making the grade.

C. Lord, B. King, J. Veenstra-VanderWeele, 2013, Journal of the American Academy of Child and Adolescent Psychiatry.

Anxiety in Individuals With Autism Spectrum Disorder: Clinical Assessment, Biology, and Treatments

B. King, A. Hardan, Lawrence K. Fung, 2016 .

Eating themselves to death: have "personal rights" gone too far in treating people with Prader-Willi syndrome?

B. King, R. Hodapp, E. Dykens, 1997, Mental retardation.

Adaptive Behavior in Young Autistic Children: Associations with Irritability and ADHD Symptoms.

Maura G. Sabatos-DeVito, G. Dawson, A. Kolevzon, 2022, Journal of autism and developmental disorders.

Fluoxetine and Repetitive Behaviors in Children and Adolescents With Autism Spectrum Disorder.

B. King, 2019, JAMA.

The Development of Emotion Regulation and Dysregulation

B. King, 1993 .

Sunsetting DSM-IV's pervasive developmental disorder.

B. King, 2014, Journal of the American Academy of Child and Adolescent Psychiatry.

Citalopram Did Not Significantly Improve Anxiety in Children with Autism Spectrum Disorder Undergoing Treatment for Core Symptoms: Secondary Analysis of a Trial to Reduce Repetitive Behaviors.

A. Pickles, E. Hollander, E. Anagnostou, 2022, Journal of child and adolescent psychopharmacology.

Psychopharmacology in mental retardation

B. King, 2002 .

Measuring Anxiety as a Treatment Endpoint in Youth with Autism Spectrum Disorder

G. Dawson, E. Cook, B. King, 2013, Journal of Autism and Developmental Disorders.

Exploring the Manifestations of Anxiety in Children with Autism Spectrum Disorders

J. Bregman, C. McDougle, E. Hollander, 2013, Journal of Autism and Developmental Disorders.

Diagnosis of Mental Disorders in People with Mental Retardation

B. Tonge, B. King, B. Goldberg, 1998 .

Psychiatric and Behavioural Disorders in Intellectual and Developmental Disabilities: Psychopharmacology in intellectual disabilities

B. King, 2007 .

Pharmacological Treatment of Mood Disturbances, Aggression, and Self-Injury in Persons with Pervasive Developmental Disorders

B. King, 2000, Journal of autism and developmental disorders.

Selective serotonin reuptake inhibitors in intellectual disability

B. King, R. Racusin, Kathleen Kovner-Kline, 1999 .

Consensus Paper: Pathological Role of the Cerebellum in Autism

Stephen R. Dager, A. Estes, D. Heck, 2012, The Cerebellum.

Issues to consider in deaf and hard-of-hearing patients. The Committee on Disabilities of the Group for the Advancement of Psychiatry.

B. King, M. Stuber, H. Work, 1997, American family physician.

Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology

Tony Charman, Eva Loth, Emily Simonoff, 2018, Journal of psychopharmacology.

Proposals for the mechanism of action of convulsive therapy: A synthesis

B. King, E. Liston, 1990, Biological Psychiatry.

Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder.

Lauren C. Shuffrey, A. Kolevzon, C. McDougle, 2021, The New England journal of medicine.

Rationale, design, and methods of the autism centers of excellence (ACE) network study of oxytocin in autism to improve reciprocal social behaviors (SOARS-B).

A. Kolevzon, C. McDougle, R. Hamer, 2020, Contemporary clinical trials.

AACAP OFFICIAL ACTION Practice Parameter for the Assessment and Treatment of Children and Adolescents With Autism Spectrum Disorder

F. Volkmar, B. King, J. McCracken, 2015 .

CM Practice Parameter for the Assessment and Treatment of Children and Adolescents With Autism Spectrum Disorder

F. Volkmar, B. King, J. McCracken, 2022 .

Revisiting the relationship between autism and schizophrenia: toward an integrated neurobiology.

N. de Lacy, B. King, Nina de Lacy, 2013, Annual review of clinical psychology.

Developmental responses of the Drosophila melanogaster embryo to localized X irradiation.

P. Bryant, B. King, 1982, Radiation research.

The Role of the Basal Ganglia in the Expression of Stereotyped, Self-Injurious Behaviors in Developmental Disorders

H. C. Cromwell, B. King, 2004 .

Practice parameters for the assessment and treatment of children, adolescents, and adults with mental retardation and comorbid mental disorders. American Academy of Child and Adolescent Psychiatry Working Group on Quality Issues.

B. King, L Szymanski, B H King, 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism.

J. Bregman, E. Hollander, L. Ritz, 2009, Archives of general psychiatry.

Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder.

B. Leventhal, C. Lord, W. McMahon, 2001, Journal of the American Academy of Child and Adolescent Psychiatry.

Pharmacologic management of psychiatric and behavioral symptoms in mental retardation.

B. King, M. State, A. Madrid, 2000, Child and adolescent psychiatric clinics of North America.

Self-injury by people with mental retardation: a compulsive behavior hypothesis.

B. King, 1993, American journal of mental retardation : AJMR.

Developmental social vulnerability as the intrinsic origin of psychopathology: A paradigm shift from disease entities to psychiatric derivatives within human diversity.

B. King, H. Morioka, S. Ijichi, 2019, Medical hypotheses.

Arbaclofen in Children and Adolescents with Autism Spectrum Disorder: A Randomized, Controlled, Phase 2 Trial

E. Cook, M. Bear, B. King, 2017, Neuropsychopharmacology.

Association of an X-chromosome dodecamer insertional variant allele with mental retardation

E. Cook, A. Palotie, E. Ginns, 1998, Molecular Psychiatry.

Commentary from the DSM-5 Workgroup on Neurodevelopmental Disorders.

S. Spence, G. Baird, C. Lord, 2012, Journal of the American Academy of Child and Adolescent Psychiatry.

Autism Spectrum Disorder: A Review.

B. King, T. Hirota, 2023, JAMA.

Severity of ASD symptoms and their correlation with the presence of copy number variations and exposure to first trimester ultrasound

B. King, S. Webb, R. Bernier, 2017, Autism research : official journal of the International Society for Autism Research.

Is schizophrenia on the autism spectrum?

Catherine Lord, C. Lord, B. King, 2011, Brain Research.

Focus on Autism and Related Conditions.

B. King, Cassie Yu, 2016, Focus.

Measuring repetitive behaviors as a treatment endpoint in youth with autism spectrum disorder

G. Dawson, E. Cook, B. King, 2015, Autism : the international journal of research and practice.

Pharmacology and genetics of autism: implications for diagnosis and treatment.

B. King, W. Raskind, Z. Brkanac, 2008, Personalized medicine.

Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND Checklist.

B. King, A. Byars, M. Sahin, 2015, Pediatric neurology.

Training of child and adolescent psychiatry fellows in autism and intellectual disability

E. Cook, J. Pruett, B. King, 2014, Autism : the international journal of research and practice.

Predictors of Caregiver Strain for Parents of Children with Autism Spectrum Disorder

Tristram H. Smith, C. McDougle, E. Hollander, 2020, Journal of Autism and Developmental Disorders.

Mental retardation: a review of the past 10 years. Part II.

B. King, M. State, E. Dykens, 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

Mental retardation: a review of the past 10 years. Part I.

B. King, M. State, E. Dykens, 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

Autism and developmental disorders: management of serious behavioral disturbance.

B. King, M. Siegel, 2014, Child and adolescent psychiatric clinics of North America.

Obsessive-compulsive symptoms in Prader-Willi and "Prader-Willi-Like" patients.

B. King, M. W. State, E. Dykens, 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

An update on pharmacologic treatments for autism spectrum disorders.

B. King, J. Bostic, 2006, Child and adolescent psychiatric clinics of North America.

Psychiatric consultation in severe and profound mental retardation.

B. King, J. McCracken, S. Forness, 1994, The American journal of psychiatry.

Children's Yale-Brown obsessive compulsive scale in autism spectrum disorder: component structure and correlates of symptom checklist.

C. McDougle, S. White, B. King, 2014, Journal of the American Academy of Child and Adolescent Psychiatry.

Paroxetine treatment of aggression and self-injury in persons with mental retardation.

B. King, T. Belin, P. Davanzo, 1998, American journal of mental retardation : AJMR.

Lies and liars: psychiatric aspects of prevarication.

C. V. Ford, B. King, M. Hollender, 1988, The American journal of psychiatry.

Outcome Measures for Clinical Drug Trials in Autism

M. Gernsbacher, B. King, D. Pearson, 2004, CNS Spectrums.

Treatment of pain in acutely burned children.

R. Sheridan, B. King, G. Saxe, 2002, The Journal of burn care & rehabilitation.

Update on diagnostic classification in autism

B. King, S. Webb, R. Bernier, 2014, Current opinion in psychiatry.

Maladaptive behavior differences in Prader-Willi syndrome due to paternal deletion versus maternal uniparental disomy.

B. King, S. Cassidy, E. Dykens, 1999, American journal of mental retardation : AJMR.

Carbamazepine reduces dopamine-mediated behavior in chronic neuroleptic-treated and untreated rats: implications for treatment of tardive dyskinesia and hyperdopaminergic states.

J. Swanson, B. King, G. Lahoste, 2000, Experimental and clinical psychopharmacology.

Pharmacological Intervention in Aggression

R. Barrnett, B. King, D. Mcquade, 2003 .

Add-On Filgrastim During Clozapine Rechallenge in Patients With a History of Clozapine-Related Granulocytopenia/Agranulocytosis

B. King, K. Toth, 2009 .

Self-injurious behavior: gene-brain-behavior relationships.

M H Lewis, H A Jinnah, S R Schroeder, 2001, Mental retardation and developmental disabilities research reviews.

Dopaminergic and Glutamatergic Interactions in the Expression of Self-Injurious Behavior

H. C. Cromwell, B. King, N. Maidment, 1998, Developmental Neuroscience.

Low-dose naltrexone inhibits pemoline-induced self-biting behavior in prepubertal rats.

R. Poland, B. King, D. Au, 1993, Journal of child and adolescent psychopharmacology.

A randomized, placebo-controlled trial of extended-release guanfacine in children with autism spectrum disorder and ADHD symptoms: an analysis of secondary outcome measures

C. McDougle, B. King, J. McCracken, 2018, Neuropsychopharmacology.

Extended-Release Guanfacine for Hyperactivity in Children With Autism Spectrum Disorder.

C. McDougle, B. King, J. McCracken, 2015, The American journal of psychiatry.

Open-label olanzapine treatment in five preadolescent children.

B. King, J. Krishnamoorthy, Jayanthi Krishnamoorthy, 1998, Journal of child and adolescent psychopharmacology.

Impact of Recent Findings on Study Design of Future Autism Clinical Trials

E. Hollander, A. Phillips, D. Guthrie, 2004, CNS Spectrums.

Deficiency in the opioid hypotheses of self-injurious behavior.

R. Poland, B. King, J. McCracken, 1991, American journal of mental retardation : AJMR.

Fluoxetine reduced self-injurious behavior in an adolescent with mental retardation.

B. King, 1991, Journal of child and adolescent psychopharmacology.

Gender Differences in Treatment-Seeking Youth with Autism Spectrum Disorder

Tristram H. Smith, C. McDougle, E. Hollander, 2021, Journal of Child and Family Studies.

An exploration of concomitant psychiatric disorders in children with autism spectrum disorder.

Tristram H. Smith, C. McDougle, B. King, 2019, Comprehensive psychiatry.

STX209 (Arbaclofen) for Autism Spectrum Disorders: An 8-Week Open-Label Study

M. Bear, B. King, J. McCracken, 2014, Journal of autism and developmental disorders.

STX209 (Arbaclofen) for Autism Spectrum Disorders: An 8-Week Open-Label Study

M. Bear, B. King, J. McCracken, 2013, Journal of Autism and Developmental Disorders.

Exploring the Manifestations of Anxiety in Children with Autism Spectrum Disorders

J. Bregman, C. McDougle, E. Hollander, 2013, Journal of Autism and Developmental Disorders.

Autism spectrum disorders: Update of evaluation and treatment

B. King, Ashraf G. Mikhail, 2001, Current psychiatry reports.

Design and Subject Characteristics in the Federally-Funded Citalopram Trial in Children with Pervasive Developmental Disorders

J. Bregman, E. Hollander, L. Ritz, 2012, Journal of autism and developmental disorders.

Measuring Anxiety as a Treatment Endpoint in Youth with Autism Spectrum Disorder

G. Dawson, E. Cook, B. King, 2014, Journal of autism and developmental disorders.

Cortical Damage Enhances Pemoline-Induced Self-Injurious Behavior in Prepubertal Rats

H. C. Cromwell, M. Levine, B. King, 1999, Pharmacology Biochemistry and Behavior.

An Observational Study With the Janssen Autism Knowledge Engine (JAKE®) in Individuals With Autism Spectrum Disorder

Matthew S. Goodwin, Andrew Skalkin, Nikolay V. Manyakov, 2019, Front. Neurosci..

Fear‐Potentiated Startle Response Is Unrelated to Social or Emotional Functioning in Adolescents With Autism Spectrum Disorders

G. Dawson, A. Estes, B. King, 2013, Autism research : official journal of the International Society for Autism Research.

Autism spectrum disorders: emerging pharmacotherapy

B. King, J. Bostic, 2005, Expert opinion on emerging drugs.

Asperger's syndrome: diagnosis and treatment.

B. King, K. Toth, 2008, The American journal of psychiatry.

Side effects from use of one or more psychiatric medications in a population-based sample of children and adolescents.

B. King, J. Bell, R. Hilt, 2013, Journal of child and adolescent psychopharmacology.

Pretreatment with MK-801 inhibits pemoline-induced self-biting behavior in prepubertal rats.

R. Poland, B. King, D. Au, 1995, Developmental neuroscience.

Developmental Aspects of Stereotypic Movement Disorder

B. King, J. Krishnamoorthy, 1998 .

The association between short and long nocturnal sleep durations and risky behaviours and the moderating factors in Taiwanese adolescents

B. King, C. Yen, T. Tang, 2010, Psychiatry Research.

Hypothesis: Involvement of the Serotonergic System in the Clinical Expression of Monosymptomatic Hypochondriasis

B. King, 1990, Pharmacopsychiatry.

Mice Exposed to Diagnostic Ultrasound In Utero Are Less Social and More Active in Social Situations Relative to Controls

B. King, S. Webb, P. Mourad, 2014, Autism research : official journal of the International Society for Autism Research.

Mental retardation (intellectual disability)

B. King, 2014 .

Promising forecast for autism spectrum disorders.

B. King, 2015, JAMA.

Treated Infections Tied to Later Risk for Mental Disorders in Children and Adolescents

B. King, 2018 .

Asperger syndrome: to be or not to be?

B. King, Bellelizabeth Foster, 2003, Current opinion in pediatrics.

Factor structure and psychometric properties of the revised Home Situations Questionnaire for autism spectrum disorder: The Home Situations Questionnaire-Autism Spectrum Disorder

Tristram H. Smith, C. McDougle, B. King, 2016, Autism : the international journal of research and practice.

Open trial lamotrigine in the treatment of self-injurious behavior in an adolescent with profound mental retardation.

B. King, P. Davanzo, 1996, Journal of child and adolescent psychopharmacology.

Association of an X-chromosome dodecamer insertional variant allele with mental retardation

E. Cook, A. Palotie, E. Ginns, 1999, Molecular Psychiatry.

Comments on self-injurious behaviour.

R. Poland, B. King, 1991, American Journal of Psychiatry.

Hyperserotoninemia and antiserotonin antibodies in autism and other disorders

B. King, G. Hanna, E. Ritvo, 1992, Journal of autism and developmental disorders.

Self-injurious behavior in mental retardation

B. King, Ashraf G. Mikhail, 1998 .

Prenatal Ultrasound and Autism: A Prediction Tool, a Risk Factor, Both or Neither?

G. Dawson, D. Spiegelman, R. Ebstein, 2017, Ultraschall in der Medizin - European Journal of Ultrasound.

Assessing Risk of Autism Spectrum Disorder in Children After Antidepressant Use During Pregnancy.

B. King, 2016, JAMA pediatrics.

Severity of ASD symptoms and their correlation with the presence of copy number variations and exposure to first trimester ultrasound

Michelle M. Garrison, B. King, S. Webb, 2017, Autism research : official journal of the International Society for Autism Research.

Side effects from use of one or more psychiatric medications in a population-based sample of children and adolescents.

B. King, J. Bell, R. Hilt, 2014, Journal of child and adolescent psychopharmacology.

STX209 (Arbaclofen) for Autism Spectrum Disorders: An 8-Week Open-Label Study

M. Bear, B. King, J. McCracken, 2013, Journal of Autism and Developmental Disorders.

Mice Exposed to Diagnostic Ultrasound In Utero Are Less Social and More Active in Social Situations Relative to Controls

B. King, S. Webb, P. Mourad, 2014, Autism research : official journal of the International Society for Autism Research.

Intellectual Disability (Mental Retardation)

B. King, A. Maerlender, L. Carlisle, 2012 .